Gufic Biosciences Reports Q1 Results: Revenue Up, Profit Down Amid Rising Costs Aug 13, 2025
More news about Gufic BioSciences
30May 25
Gufic Biosciences Reports Mixed Q4 Results: Revenue Up, Profits Down
Gufic Biosciences' Q4 financial results show a 5.13% increase in revenue to ₹2.05 billion, but a significant decline in profitability. EBITDA fell to ₹266.00 million from ₹342.30 million year-over-year, with EBITDA margin dropping to 12.99% from 17.55%. Net profit sharply decreased to ₹80.00 million from ₹200.00 million in the previous year. The company faces challenges in maintaining profit margins despite revenue growth.